Market Access and HTA: What Every Pharmaceuticals Stakeholder Should Know 2016

Today, manufacturers face many challenges and opportunities when dealing with the innovative approaches to demonstrate a value and affordability of a pharmaceutical product to other stakeholders. Key elements for successful delivery of value and affordability include market access and HTA (Health Technology Assessment). Market access is a process of identifying, creating and communication value to the key stakeholders. The global value needs to reflect on a local level, thus remaining relevant to the local setting. The setting specific value is reflected through HTA processes.